Article
Gilead nears deal to buy Immunomedics for more than $20 bln -WSJ
Rating:
0.0
Views:
46
Likes:
1
Library:
1
(Reuters) – Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday. A deal for Immunomedics, whose cancer therapy Trodelvy is FDA-approved as a third-line treatment […]
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value